Reduction in CD4 Central Memory T-Cell Subset in Costimulation Modulator Abatacept-Treated Patients With Recent-Onset Type 1 Diabetes Is Associated With Slower C-Peptide Decline

We previously reported that continuous 24-month costimulation blockade by abatacept significantly slows the decline of β-cell function after diagnosis of type 1 diabetes. In a mechanistic extension of that study, we evaluated peripheral blood immune cell subsets (CD4, CD8-naive, memory and activated...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Orban, Tihamer, Beam, Craig A., Xu, Ping, Moore, Keith, Jiang, Qi, Deng, Jun, Muller, Sarah, Gottlieb, Peter, Spain, Lisa, Peakman, Mark
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2014
Matèries:
Immunology and Transplantation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4171657/
https://ncbi.nlm.nih.gov/pubmed/24834977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db14-0047
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars